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The Journal of Immunology
Regulatory B Cells Shape the Development of Th2 Immune
Responses in BALB/c Mice Infected with Leishmania major
Through IL-10 Production
Catherine Ronet,*,† Yazmin Hauyon-La Torre,*,† Me´lanie Revaz-Breton,*,†,1
Be´atris Mastelic,*,†,2 Fabienne Tacchini-Cottier,*,† Jacques Louis,†,‡ and Pascal Launois*,†
Recent evidence indicates that B cells are required for susceptibility to infection with Leishmania major in BALB/c mice. In this
study, we analyzed the role of the IL-10 produced by B cells in this process. We showed that B cells purified from the spleen of
BALB/c mice produced IL-10 in response to stimulation with L. major in vitro. In vivo, early IL-10 mRNA expression is detected
after L. major infection in B cells from draining lymph nodes of susceptible BALB/c, but not of resistant C57BL/6 mice. Although
adoptive transfer of naive wild-type B cells prior to infection in B cell-deficient BALB/c mice restored Th2 cell development and
susceptibility to infection with L. major of these otherwise resistant mice, adoptive transfer of IL-102/2 B cells mice did not. B cells
stimulated by L. major, following in vitro or in vivo encounter, express the CD1d and CD5 molecules and the IL-10 produced by
these cells downregulate IL-12 production by L. major-stimulated dendritic cells. These observations indicate that IL-10 secreting
B cells are phenotypically and functionally regulatory B cells. Altogether these results demonstrate that the IL-10 produced by
regulatory CD1d+ CD5+ B cells in response to L. major is critical for Th2 cell development in BALB/c mice. The Journal of
Immunology, 2010, 184: 886–894.
I
n addition to their Ig secreting function, B cells have been
demonstrated to play a role as APCs. Recently, using live
imaging techniques, the APC function of B cells was con-
firmed by showing that Ag-specific B cells present in lymph nodes
(LNs) acquire, process, and present soluble Ag to specific CD4+
T cells with a greater efficiency than dendritic cells (DCs) (1).
B cells are also capable of cytokine production. Two populations
of effector B cells named Be1 and Be2 that produced distinct
patterns of cytokines (i.e., IL-12/IFN-g and IL-4, respectively)
have been detected in vitro and in vivo. The cytokines produced by
Be1 and Be2 have been described to modulate the differentiation
of CD4+ T cells toward Th1 or Th2 cells, respectively (2). Indeed,
IFN-g–producing and IL-12–producing B cells have been identi-
fied in mice infected with pathogens that induce Th1 immunity (i.
e., Toxoplasma gondii) (2, 3), whereas IL-4–producing B cells
were detected in mice infected with parasites that induce Th2
immunity (i.e., Heligmosomoides polygyrus) (2, 4).
B cells are also able to produce regulatory cytokines such as IL-10 in
vitro (5–7). The in vivo role of IL-10–producing B cells was first
demonstrated in a murine model of experimental autoimmune en-
cephalomyelitis (EAE). In this model, the exacerbated encephalomy-
elitis that develops after immunization with myelin oligodendrocyte
glycoprotein peptide in B cell-deficient mice was demonstrated to be
the consequence of a deficiency of IL-10–producing B cells (8). In-
deed, in the absence of IL-10 production by B cells, the proin-
flammatory type 1 immune response persisted, and mice did not
recover (8). The involvement of the IL-10–producing B cells named
regulatory B (Breg) cells was then extended to immunopathology
developing in other autoimmune diseases such as collagen induced
arthritis, ulcerative colitis, and lupus (9–11).
Recently, IL-10 produced by B cells was also described during
parasitic diseases. B cells from mice infected with Schistosoma
mansoni proliferate, secrete IL-10, and promote the development
of Th2 immune response (12). Purified B cells from BALB/c mice
infected with Leishmania major, Brugia malayi, or Brugia pa-
hangi produced IL-10 in response to restimulation with soluble
Leishmania or microfilarial extract, respectively (5, 13). In addi-
tion, it was recently described that stimulation of naive splenic
BALB/c B cells with Leishmania infantum tryparedoxin lead to
IL-10 production (14). Altogether, these observations demonstrate
that B cells could produce IL-10 in response to parasite Ags.
However, the exact role of the IL-10 producing B cells in vivo in
parasitic disease is not yet established.
Studies in vivo, using the murine model of infection with
L. major, have established that resistance and susceptibility to
infection with this protozoan parasite are correlated with the ac-
tivation of parasite-reactive CD4+ Th1 or Th2 cells, respectively
(15). IL-4 has been shown for a long time to play a predominant
role in directing the functional differentiation of Leishmania-
reactive CD4+ Th2 T cells observed in susceptible BALB/c mice
postinfection with L. major (16). However, the use of IL-4Ra2/2
BALB/c mice has generated controversial results. Indeed, IL-
4Ra2/2 BALB/c mice infected with L. major either contained
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infection (17) or still developed progressive disease (18). These
observations suggest that another cytokine than IL-4 might be
involved in susceptibility to infection with L. major. Results
showing that IL-102/2 and IL-4Ra2/2 IL-102/2 BALB/c mice
control parasite replication demonstrate that IL-10 signaling
contribute to susceptibility to L. major infection (19).
We have recently demonstrated that B cells are required for sus-
ceptibility andTh2 cell development inBALB/cmice infectedwithL.
major LV39 (20). We (20) and others (21) have also established that
the ability of B cells to direct the immune response in BALB/c mice
toward a Th2 phenotypewas dependant upon their capacity to present
Ag to T cells rather than upon their production of specific IgG Abs.
The aim of the current study was to analyze the role of cytokine
secreted by B cells, particularly IL-10, in the polarization of the
Th2 cell response and the susceptibility of BALB/c mice to in-
fection with L. major LV39. We clearly demonstrated that IL-10
produced by B cell is necessary for susceptibility to infection with
L. major LV39 in BALB/c mice and for the Th2 cell development.
The effect of IL-10 producing B cells was shown, at least in vitro,
to stem IL-12 production by DCs.
Materials and Methods
Mice
mMTmice on the C57BL/6 background were obtained from Kitamura et al.
(22). These mice were backcrossed 10 times to the BALB/c background.
Flow cytometry analysis was used to confirm the absence of CD19+ cells in
the peripheral blood of these mice. IL-102/2 BALB/c mice were kindly
provided by Dr. J. P. Farrell (University of Pennsylvania, Philadelphia, PA).
Female BALB/c and C57BL/6 were purchased from Harlan (Horst, The
Netherlands). Mice were bred and maintained in the animal facilities of the
Swiss Institute for Experimental Cancer Research under pathogen-free
conditions (Epalinges, Switzerland). The maintenance and care of mice
compliedwith theguidelines of theUniversity ofLausanneEthicCommittee.
Parasites and infection
L. major LV39 (MRHO/SU/59/P), isolated from a gerbil reservoir in
southern Russia, were maintained in vivo and grew in vitro as previously
described (23). For infection, mice were injected in hind footpads with 33
106 stationary phase L. major promastigotes in a volume of 50 ml of
DMEM. Size of footpad lesions was measured with a Vernier caliper and
compared with the thickness of the uninfected footpad. Footpad tissues
were used to create limiting dilutions for quantification of viable parasite
burdens as previously described (23).
MACS and adoptive transfer of B cells to BALB/c mMT mice
Bcellswere purified from spleen cells fromeither naiveBALB/c or IL-102/2
BALB/c mice using Magnetic Activated Cell Sorting (MACS, Miltenyi
Biotec, Bergisch Gladbach, Germany). Briefly, total spleen cells were in-
cubated with a mixture of biotin-conjugated Abs and anti-Biotin mi-
crobeads against CD43 (Ly-48), CD4 (L3T4), and Ter-119 to remove
T cells, NK cells, DCs, macrophages, granulocytes, and erythroid cells.
After immobilization of all these cells with a magnet, untouched CD19+
cells were recovered. Purity of B cells was .98% as determined by flow
cytometry analysis using anti-CD19 mAbs (1D3) from eBioscience (San
Diego, CA). BALB/c mMT mice were reconstituted with 107 purified B
cells by the i.v. route and infected with L. major 3 d later.
Lymphocyte stimulation and detection of cytokines in
supernatants
Total LN cells. Popliteal LN cells (5 3 106) were stimulated with UV-
irradiated L. major promastigotes (13 106) in a final volume of 1 ml. Cells
were cultured in DMEM supplemented with 5% heat inactivated FCS, 2
mM L-glutamine, 53 1025 M 2-bME, and 10 mM Hepes in an atmosphere
of 7% CO2 at 37˚C. All media and FCS used in this study were certified
endotoxin free. Culture supernatants were collected after 72 h and stored
at 220˚C until use.
B cells. B cells purified by MACS (2 3 106 cells) were stimulated in vitro
with complete DMEM medium alone, L. major live promastigotes (1–5
parasites/cell), LPS (1 mg/ml, Escherichia coli, serotype 055:B5; Sigma-
Aldrich, Epalinges, Switzerland), CpG (1 mg/ml, ODN1826; InvivoGen,
Toulouse, France). Culture supernatants were collected after 24 h and
stored at 220˚C until use.
ELISA. IFN-g was measured in supernatants by ELISA as described (20).
Mouse recombinant IFN-g (supernatant of L1210 cells transfected with the
murine IFN-g, a gift of Y. Watanabe, Kyoto University, Kyoto, Japan) was
used as standard. IL-10 and IL-4 were measured by ELISA using com-
mercial kits (BD Biosciences, Allschwill, Switzerland). The limits of de-
tection of these assays were 10 IU/ml for IFN-g and 20 pg/ml for IL-4 and
IL-10. An ELISA kit with a sensitivity of 15 pg/ml was used for the de-
tection of IL-12p70 (eBioscience).
FACS analysis
Single-cell suspensions were first incubated 10 min with an anti-FcgRII/III
mAb (Fcblock, 2.4G2), followed by a 20 min exposure to cell surface
staining performed with the following Abs: CD19 (1D3), CD21 (7G6),
CD23 (B3B4), IgMa (DS-1), and IgDa (AMS9.1). mAbs were obtained
from BD Biosciences, and CD5 (53-7.3) and CD1d (1B1) were provided
by eBioscience. PE-cychrome5-streptavidin was purchased from BD Bi-
osciences. Cells were analyzed in PBS containing 3% FCS using
a FACSCalibur flow cytometer (BD Biosciences) and FlowJo software
(TreeStar, Ashland, OR).
Flow cytometry analysis of IL-10–producing B cells
Splenic or LN B cells were purified by MACS and were stimulated in
medium alone, or with either L. major or with CpG, during 24 h. IL-10–
producing cells were isolated using the IL-10 secretion assay in accor-
dance to the manufacturer’s instructions (Miltenyi Biotec). Briefly, a rat
anti–IL-10 Ab conjugated to cell surface marker specific Ab (IL-10 catch
reagent) was attached at the surface of B cells. Cells were then incubated
45 min at 37˚C and IL-10 secreted bound to IL-10 catch reagent on the
secreting cells. Then the cytokine is labeled with an IL-10–detecting mAb
conjugated with PE. Finally, IL-10–producing cells were purified using
anti-PE microbeads. Thereafter, enriched IL-10–secreting B cells were
stained for specific markers (CD1d, CD5, IgM, IgD, CD21, CD23) to
phenotype further IL-10+ B cells.
RNA extraction, cDNA preparation, and real-time RT-PCR
Total RNAwas isolated from total LN cells or purified cells using RNeasy
Mini Kit (Qiagen, Hombrechtikon, Switzerland) according to the manu-
facturer’s instructions doing the optional DNase treatment. cDNA prepa-
ration was carried out following standard procedures using dNTPs (Roche,
Basel, Switzerland) and Superscript II reverse transcriptase (Invitrogen,
Basel, Switzerland) according to the manufacturer’s instruction. PCR am-
plification was prepared using LightCycler Faststart DNA Master SYBR
Green I kit (Roche Diagnostics AG, Rotkreuz, Switzerland) and quantitative
PCR amplifications were performed with the LightCylcer 1.5 system (Ro-
che) according to the manufacturer’s instructions. The primers for the real-
time PCR were the following: HPRT Fw 59-GTTGGATATGCCCTTGAC-
39; Rev 59-AGGACTAGAACACCTGCT-39; IL-10 Fw 59-ACCTGCTCCA
CTGCCTTGCT-39; and IL-10 Rev 59-GGTTGCCAAGCCTTATCGGA-39.
The results were analyzed using the comparative threshold cycle method
(DDCT) for relative quantification of gene expression normalized to the
housekeeping gene HPRT. In some experiments, results are expressed as the
fold change of the IL-10 mRNA in cells from infected mice compared with
naive cells, which was defined as the reference.
Dendritic cell generation and coculture
Bone marrow cells were flushed from long bones with RPMI. Erythrocytes
were lysed with RBC lysis buffer (150 mMNH4Cl, 1.0 mMKHCO3, and 0.1
mMNa2EDTA).DCsweregeneratedbyplatingofbonemarrowprogenitors (2
3 105 cells/ml) in complete RPMI medium supplemented with 30% condi-
tionedmedium fromGM-CSF–transducedAO-2 cells as previously described
(24). After 3 d, fresh DC medium was added. On day 6, DCs were recovered
and stimulated with L. major promastigotes (ratio 5:1) or LPS (1 mg/ml).
In some experiments, DCs were stimulated in a final volume of 400 ml
during 24 hwith 200ml mediumorL.majorpromastigotes in presence of 200
ml of B cell supernatants that have been stimulated with medium alone or
with L. major.
Results
B cells produce IL-10 after stimulation by L. major in vitro
Cytokine production by B cells purified from spleens of naive
BALB/c mice stimulated by L. major promastigotes (from one to
five parasites/cell) was analyzed. Although IL-10 was already
produced by B cells from naive BALB/c mice in response to
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stimulation with L. major at one parasite/cell (data not shown),
optimal IL-10 production was detected with five parasites/cells
(Fig. 1). In addition, soluble Leishmania Ags (SLA) induce similar
IL-10 secretion by purified B cells than live L. major promastigote
(Fig. 1). In contrast, whatever the number of parasites used for the
stimulation, we were unable to detect IFN-g, IL-4, and IL-12p70
secretion in the supernatant of stimulatedB cells (data not shown). B
cells from naive BALB/c mice produced IL-10 but no IL-4, IFN-g,
and IL-12 p70 upon stimulation with LPS or CpG (data not shown).
CD19+ cells from BALB/c mice produced IL-10 in vivo during
the first days of infection with L. major
It has been clearly established that, in the murine model of infection
with L. major, the cytokine environment during the early phases of
infection is critical for the differentiation of CD4+ T cells toward the
Th1 orTh2phenotype (25, 26). Thus, to determinewhether IL-10was
produced during this critical window of time, susceptible BALB/c
and resistant C57BL/6 mice were infected in the footpads with L.
major promastigotes and the kinetics of IL-10 mRNA expression in
draining LN cells determined. Results in Fig. 2A show that IL-10
mRNA expression was detected in both susceptible BALB/c and
resistant C57BL/6 mice during the first 3 d of infection with a peak
on day 1 that rapidly returned to the baseline levels at day 3.
To determinewhether B cells are responsible for the IL-10mRNA
burst detected postinfection with L. major, B cells were purified
from draining LN cells of both BALB/c and C57BL/6 mice and
analyzed for IL-10 mRNA expression. Results clearly showed an
increase of IL-10 mRNA transcripts 1 d postinfection with L. major
exclusively in CD192 cells in C57BL/6 mice but in both CD19+
and CD192 cells in BALB/c mice (Fig. 2B). These data suggest that
B cells are a source of IL-10 in BALB/c mice infected with L. major
LV39. However, is necessary to note that only living parasites in-
duce this phenotype, because when BALB/c mice were inoculated
with SLA, a peak of IL-10 mRNA transcripts was observed in
draining LN cells but mainly in CD192 cells (data not shown).
Transfer of IL-102/2 B cells into mMT BALB/c mice did not
modify the resistance of these mice to infection with L. major
We have previously reported that adoptive transfer of naive B cells
into otherwise resistant BALB/c mMT mice restored susceptibility
to infection with L. major (20). In an attempt to determine whether
the IL-10 produced by B cells was necessary or not to redirect
susceptibility to L. major in BALB/c mice, we analyzed the effect
of the adoptive transfer of naive B cells from IL-102/2 BALB/c
mice into BALB/c mMT on the course of infection and the path-
way of Th cell differentiation.
As already demonstrated, BALB/c mMT mice infected with L.
major LV39 were resistant to infection. Whereas BALB/c mMT
mice reconstituted with wild-type (WT) B cells developed pro-
gressive lesions similar to those observed in BALB/cmice, BALB/c
mMT mice reconstituted with IL-102/2 B cells controlled the de-
velopment of lesions (Fig. 3A). At the time of parasite burden de-
termination, the percentages of draining LN B cells were: 23.4%6
3.8% and 26.6% 6 2.3% of lymphocytes in BALB/c mMT recon-
stituted with WT B cells or IL-102/2 B cells, respectively.
Estimation of the number of parasites in lesions clearly showed
that parasites growth was controlled in BALB/c mMT mice re-
constituted with IL-102/2 B cells but not in BALB/c mMT mice
reconstituted with WT B cells (Fig. 3B).
Analysis of cytokines production in supernatants of specifically
stimulated draining LN cells at the end of infection (day 48) revealed
that whereas BALB/c mMT mice reconstituted with WT B cells
FIGURE 1. B cells from BALB/c mice secrete IL-10 after stimulation in
vitro byL.majorLV39. Purified splenicBcells fromnaiveBALB/cmicewere
cultured in presence of medium alone, L. major LV39 (five parasites/cell),
SLA, or 1mg/ml ofLPSorCpG.After 24hof stimulation, IL-10production in
culture supernatants was measured by ELISA. Data are the mean6 SD of 10
experiments. pp, 0.05 compared with unstimulated B cells.
FIGURE 2. IL-10 mRNA expression increase in LN cells postinfection
with L. major. BALB/c or C57BL/6 mice were infected with 3 3 106 L.
major LV39 in the footpad, and draining LN cells were collected during
the first 3 d of infection for IL-10 mRNA expression analysis by real-time
PCR. Three mice per group were sacrificed at each time point. A, IL-10
mRNA expression in draining LNs was determined during the first 3 d of
infection. mRNA levels were normalized to the level in noninfected con-
trol mice for each background. Data are the mean 6 SD of IL-10 mRNA
values from one experiment representative of three. B, CD19+ and CD192
cells were purified from draining LNs of C57BL/6 and BALB/c mice by
MACS as described in Materials and Methods. IL-10 mRNA expression
was analyzed daily during the first 3 d of infection. In each background,
results are presented as fold increase of IL-10 transcripts in CD19+ and
CD192 cells postinfection as compared with CD19+ and CD192 cells-
from day 0, respectively, defined as the reference (fold change 1). pp ,
0.05 compared with uninfected cells (day 0).
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mounted a typicalTh2 cell responsewith high levels of IL-4 similar to
those observed in infected BALB/c mice, BALB/c mMT mice re-
constitutedwith IL-102/2Bcells developed aTh1 responsewith high
levels of IFN-g and low levels of IL-4 (Fig. 3C). IFN-g and IL-4–
producing cells were analyzed by intracellular staining. The absolute
number of IFN-g+–producing cells among the CD4+ T cells in the
drainingLNswas similar amongall thegroupofmice. Incontrast, five
times more CD4+ IL-4+ cells were measured in BALB/c mice and
mMT mice reconstituted with WT B cells than in mMT mice and
mMT mice reconstituted with IL-102/2 B cells (data not shown).
IL-10 production was also analyzed in supernatants of draining
LN stimulated with L. major. First and interestingly, cells from
BALB/c mMT produced lower IL-10 levels than cells from BALB/
c mice. In addition, whereas draining LN cells from BALB/c mMT
mice reconstituted with WT B cells produced IL-10 in response to
stimulation with L. major in a similar amount compared to cells
from BALB/c mice, cells from BALB/c mMT mice reconstituted
with IL-102/2 B cells did not (Fig. 3C).
These results indicate that the IL-10 produced by B cells is
involved in the induction of a Th2 cell response and in suscepti-
bility to L. major LV39 in BALB/c mice.
IL-10 produced by B cells downregulates IL-12 production by
DCs in vitro after L. major stimulation
IL-10 is a potent antiinflammatory cytokine, which was identified
as a Th1 inhibitor due to its ability to prevent IL-12 secretion by
DCs (27). Thus, we analyzed the effect of the IL-10 produced by B
cells stimulated with L. major stimulation on the capacity of DCs
to produce IL-12 in response to this parasite.
First, we analyzed IL-12p70 production by bone marrow DCs
(BMDCs) derived from WT BALB/c mice in response to L. major
stimulation. As shown in Fig. 4A, BMDCs from BALB/c mice did
not produce IL-12p70 in response to L. major stimulation. As
a control, substantial amount of IL-12p70 (500 pg/ml)was produced
by BMDCs cells in response to stimulation by LPS (Fig. 4A). In-
terestingly, stimulationofBMDCs fromBALB/cmicewithL.major
induced some IL-10 production (Fig. 4A). As IL-10 is described as
a cytokine able to prevent IL-12 production by DCs, similar DC
stimulations were done with BMDCs from IL-102/2 BALB/c. As
shown in Fig. 4B, DCs from IL-102/2 BALB/c mice produced
significant amount of IL-12p70 in response to L. major. These re-
sults suggest that autocrine IL-10 produced by BMDCs in response
to L. major stimulation downregulate IL-12p70 production.
As BMDCs from IL-102/2 BALB/c produced significant
amount of IL-12p70 after L. major stimulation, these cells were
further used to analyze the suppressive effect of IL-10 secreted by
B cells on DC activity.
First, we analyzed the effect of IL-10 produced by WT B cells in
vitro in response to L. major on the capacity of BMDCs from IL-
102/2 BALB/c mice to produce IL-12p70. Thus, BMDCs from IL-
102/2 BALB/c mice were stimulated during 24 h with L. major in
the presence of supernatants of either unstimulated or L. major-
stimulated B cells. Fig. 4C clearly shows that in contrast to super-
natants of unstimulated B cells, supernatants of BALB/c B cells
stimulatedwithL.major inhibited IL-12p70 production of IL-102/2
BMDCs stimulated with L major. The same results were obtained
with supernatants of LPS-stimulated B cells (data not shown).
FIGURE 3. IL-10–producing B cells are necessary for susceptibility of BALB/c mice to infection with L. major LV39. BALB/c mMT mice were re-
constituted i.v. with 107 B cells from either WT or IL-102/2 BALB/c mice. Three days after the cell transfer, mice were inoculated with 3 3 106 L. major
LV39 in the footpad. Similarly infected but not reconstituted BALB/c mMT mice, BALB/c, and C57BL/6 mice were used as controls. Results were com-
parable in three independent infections. Results represent the mean6 SD of five individual mice per group. A, Size of the footpad lesion from the designated
mice infected with L. major LV39, monitored using a Vernier caliper. B, Numbers of parasites in lesions at the end of infection in the designated mice were
quantified as described in Materials and Methods. C, Draining LN cells obtained at the end of infection in the designated mice were stimulated with UV-
irradiated L. major. After 72 h of culture, IFN-g, IL-4, and IL-10 production were measured in supernatants as described inMaterials and Methods. For each
determination, background levels of cytokines in supernatants of cultures without L. major were subtracted. pp , 0.05 compared with BALB/c mice.
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To confirm that IL-10 present in supernatants ofB cells stimulated
by L. major was indeed responsible for IL-12p70 downregulation
observed above in IL-102/2 BMDCs (Fig. 4C), IL-102/2 BMDCs
were stimulated by L. major in the presence of supernatants from
IL-102/2 B cells stimulated with L. major. Fig. 4D clearly shows
that supernatants of IL-102/2 B cells stimulated with L. major did
not inhibit the IL-12p70 produced by IL-102/2 BMDCs stimulated
by L. major. Altogether, these results demonstrated that IL-10
produced by B cells in response to L. major downregulate the
IL-12p70 produced by BMDCs.
Unfortunately, we were unable to study the regulation by B cells
derived IL-10 on IL-12p70 production by DCs in vivo during the
early steps of infection, because induction of IL-12p70 in L. major
infected mice is restricted to few numbers of DCs during the first
days of infection (28).
Characterization of B cell-producing IL-10 in response to
L. major
In order to determine the phenotype of B cells secreting IL-10 after
L. major stimulation in vitro, we enriched the IL-10–producing B
cells with an IL-10 secretion assay kit (Miltenyi Biotec) and an-
alyzed the expression of specific markers of B cells on the IL-10
negative and positive enriched B cell population.
As shown in Fig. 5A, IL-10–producing B cells were mostly
CD5+ after stimulation with L. major (76.5%) or with CpG
(70.2%). Interestingly, the few IL-10–producing B cells detected
FIGURE 4. IL-10–producing B cells prevent IL-12 secretion by DCs stimulated with L. major. A and B, BMDCs were generated fromWT (A) or IL-102/2
(B) BALB/c mice and stimulated in vitro either with L. major or LPS (1 mg/ml). After 24 h of stimulation, levels of IL-12p70 and IL-10 produced in the
supernatants of cultures were determined by ELISA. For each determination, background levels of cytokines detected in supernatants of unstimulated cultures
were subtracted. Bars represent the mean6 SD of triplicate determinations. Similar results were obtained in three individual experiments. C and D, BMDCs
were generated from IL-102/2 BALB/c mice and stimulated during 24 h in vitro with L. major in presence of supernatant of either unstimulated or L. major-
stimulated WT B cells (C) or IL-102/2 B cells (D). Secretion of IL-12p70 by B cells was determined by ELISA. Bars represent the mean6 SD of triplicate
determinations. Results presented are from one of three experiments with comparable results. SN, supernatants.
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in unstimulated culture were also CD5+ (71.2%). However,
whereas 35.9% of IL-10–producing cells are CD5+ and CD1d+
after L. major stimulation, only 16.6% of IL-10–producing B cells
in responses to CpG were CD5+ and CD1d+ (Fig. 5A). As a con-
trol, without any stimulation, 8.8% of IL-10–producing B cells are
CD1d+ and CD5+ (Fig. 5A). In addition, non-IL-10–producing B
cells are CD52 and CD1d2 whatever the stimulation used.
Expression of characteristic markers of B cell subsets such as
CD21, CD23, IgD, and IgMwere also analyzed in IL-10–producing
B cells. A downregulation of CD21 and CD23 expression was
observed in B cells stimulated with L. major as compared with
unstimulated or CpG stimulated B cells (58.2% versus 92.7% and
91%, respectively, for CD21; 53.2% versus 90.9% and 76.5%,
respectively, for CD23). Whereas no difference was observed in
IgM expression in B cells whatever the stimulus used (L. major or
CpG), a downregulation of IgD was detected in IL-10–producing
B cells after L. major and CpG stimulation as compared with
unstimulated B cells.
Altogether these resultsdemonstrated that invitro IL-10–producing
B cells after L. major are CD5+, CD1d+, CD21low, and CD23low and
that this phenotype is specific to L. major because IL-10–producing
B cells after stimulation with CpG are CD5+, CD1d2, CD21high,
and CD23high.
To demonstrate that B cells producing IL-10 also expressed CD5
and CD1d in vivo, purified B cells were isolated from the draining
LN 1 d postinfection with L. major and characterized for their
expression of CD5 and CD1d markers. In accordance with the
phenotype of IL-10–producing B cells after L. major stimulation
in vitro, 14.1% of IL-10–producing B cells 1 d postinfection with
L. major are CD5+ and CD1d+ (Fig. 5B). As controls, only 0.91%
non-IL-10–producing B cells are CD5+ and CD1d+ 1 d post-
infection with L. major.
In conclusion, IL-10 production by B cells after L. major
stimulation is confined to a small, discrete population of CD5+ and
CD1d+ B cells.
Discussion
Results obtained in this study showed that the IL-10 produced by B
cells in response to L. major LV39 plays an important role in the
development of susceptibility to the infection. First, we described
that purified B cells stimulated in vitro with L. major secrete IL-10.
Moreover, IL-10 expression is detected in purifiedCD19+ cells from
draining LNs in susceptible but not in resistant mice in the first days
postinfection, a window of time particularly important for Th dif-
ferentiation (15). Furthermore, in contrast to the effect of adoptive
transfer of B cells fromBALB/cmice into BALB/cmMTmice prior
to infection with L. major LV39 (20), transfer of B cells from IL-
102/2 BALB/c mice into BALB/c mMT mice restore neither dis-
ease progression nor Th2 cell development in these otherwise re-
sistantmice. But, it is important to note that the effect of B cell IL-10
may be limited to the LV39-specific strain of L. major.
It has been described that IL-4 plays a dominant role in the sus-
ceptible phenotype observed in the BALB/c mice postinfection with
L. major (16). However, experiments using IL-4Ra2/2-deficient
mice have generated controversial results. Indeed, IL-4Ra2/2 mice
infectionwithL.major either contained infection during the first 3mo
(17) or developed progressive disease with similar kinetics to WT
BALB/cmice (19). These results suggest that cytokines, in addition to
IL-4, are responsible for susceptibility to infection with L. major.
Results showing that IL-4Ra2/2 IL-102/2 mice control parasite
replication and displayed a resistance phenotype comparable to that
of C57BL/6 mice demonstrated that IL-10 might play a role in sus-
ceptibility to infection with L. major. Moreover, IL-10–deficient or
WT mice treated with anti–IL-10R mAb were resistant to L. major
LV39 infection but still less so than the IL-4Ra2/2 IL-102/2 mice
(19). Taken together, these observations indicate that both IL-10 and
IL-4 participate in the susceptibility of BALB/c mice.
Several different populations of cells have been described as IL-
10 producers after L. major infection. Following infection with L.
major, IL-10 mRNAwere detected in CD4+ T cells from BALB/c
mice (29). Among T cells, CD4+CD25+ T cells named regulatory
T (Treg) cells have been shown to have suppressive activity re-
lated to their production of IL-10. Indeed, in L. major–resistant
C57BL/6 mice, Treg cells have been shown to inhibit effector’s
responses by IL-10–dependent and –independent mechanisms (30)
to maintain low levels of persistent parasites and consequently
CD4+ T cell memory (31). However, recently it has been dem-
onstrated that the IL-10 produced by CD4+ T cells other than Treg
cells is responsible for susceptibility to infection (32, 33).
In addition to T cells, macrophages have also been described as
a source of IL-10 in response to Leishmania. After ligation and
internalization of IgG-opsonized parasites through their FcRs,
macrophages secrete IL-10 (34–38). However, we have already
demonstrated that IL-10 production by LN-stimulated cells from
BALB/c mMT mice reconstituted with immune serum do not
differ from those observed in unreconstituted mice, suggesting
that specific IgG do not contribute to susceptibility to infection
with L. major (20).
Recently, in an experimental model of visceral leishmaniasis
induced by Leishmania donovani, NK cells were described as
a novel source of IL-10 (39). Although the role of IFN-g produced
by NK cells is still debated in cutaneous leishmaniasis (40, 41),
the role of IL-10 potentially produced by NK cells has not yet
been evaluated.
Although B cells have also been described as producing IL-10 in
response to L. major stimulation in vitro (5, 14), the exact role of
this cytokine produced by B cells in vivo has not been established.
In this report, we clearly demonstrate that after L. major infection,
B cells are also a source of IL-10 and that this IL-10 production
influences the susceptibility of infection with L. major. Indeed,
whereas otherwise BALB/c mMT mice reconstituted with WT B
cells develop progressive lesions similar to those observed in
BALB/c mice, BALB/c mMT mice reconstituted with IL-102/2 B
cells contain the development of lesions and develop a Th1 re-
sponse. The results presented in this paper showing that IL-10
produced by B cells, a potential APC, is necessary for suscepti-
bility to infection with L. major are in agreement with the ob-
servations demonstrating that IL-10 produced by APCs is needed
for susceptibility to infection with L. major (42).
The effect of IL-10 on susceptibility of BALB/c mice to L. major
infection appears critically dependent on the nature of its cellular
source. In this context, it has been demonstrated that Tg C57BL/6
mice expressing IL-10 under the control of the IL-2 promoter,
directing the expression of IL-10 in T cells, remained resistant to
L. major infection and developed a Th1 response comparable to
that of WT C57BL/6 mice (43). In contrast, C57BL/6-resistant
mice that express an IL-10 transgene under the control of the
MHC II Ea promoter, directing the expression of IL-10 mainly in
APCs, were susceptible to L. major (42).
The absence of IL-10 production by B cells in the first days of
infection in resistant mice also suggests that in susceptible mice,
B cells facilitate lesion development by suppressing the differen-
tiation of protective Th1 effector cells. A recent report showed that
CpG-activated neonatal B cells inhibited IL-12 secretion by DC
through an IL-10–dependent mechanism (44). Furthermore, in the
EAE model, recovery was associated with the suppression of IL-12
production by DCs by IL-10 secreted by B cells (8, 45). In accor-
dance with these results, we demonstrated that L. major-activated
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B cells limit the capacity of DCs to produce IL-12. First, super-
natants of L. major stimulated B cells from BALB/c mice that
contained IL-10 inhibit IL-12p70 production of DCs stimulated
with L major. Secondly, in contrast to adoptive transfer of WT B
cells, adoptive transfer of IL-102/2 B cells did not promote the
development of the Th2 immune response in infected mice.
Recently, Breg cells have been identified in experimental models
of autoimmunity, cancer, and infections. The regulatory function of
these B cells was shown to be mediated by the production of IL-10.
Different subsets of Breg cells distinguished by their surface
phenotype and their immunoregulatory properties (i.e., down-
regulating IL-12 production or costimulatory molecules on APCs
FIGURE 5. CD5+CD1d+ B cell subsets secrete IL-10 after stimulation by L. major. A, Phenotype of IL-10+– or IL-102–producing splenic B cells in vitro.
Purified CD19+ splenocytes were stimulated by medium alone, L. major, and CpG for 16 h. Thereafter, IL-10–producing cells were enriched using the IL-
10 secretion assay strategy, and cell surface molecule expression on IL-10+ and IL-102 B cells was determined by FACS analysis. Similar results were
obtained in three individual experiments. B, Phenotype of IL-10–producing B cells in the draining LNs 1 d postinfection with L. major. CD19+ cells were
purified and IL-10–producing cells were enriched using the IL-10 secretion assay strategy. CD1d and CD5 expression was analyzed by FACS analysis on
IL-10+ and IL-102 B cells. Similar results were obtained in two individual experiments.
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or even inducing Treg cells) have been described (46). The phe-
notype of IL-10–producing B cells after L. major stimulation is
clearly CD19+, CD5+, CD1d+, CD21low, and CD23low. These B
cells share some phenotypic markers with the B cell subsets al-
ready described: CD5+ B1 cells, CD1d+ CD23+ IgM+ IgD+ tran-
sitional T2, and CD1d+ CD23+/2 IgM+ IgD+/2 marginal zone B
cells. Interestingly, all these B cell subpopulations have been de-
scribed as potential Breg cells (47). We can rule out that IL-10–
producing B cells after L. major stimulation are B1 cells because
purification of B cells was done by negative selection using a mAb
against CD43, a marker expressed on B1-B cells (48). In addition,
using B1-depleted BALB/c mice, Babai et al. (49) have clearly
demonstrated that B1-B cells do not contribute to the suscepti-
bility of BALB/c mice to infection with L. major.
With respect to the phenotype of the IL-10–producing B cells
after L. major stimulation, we cannot conclude whether these cells
are T2 or MZ B cells. Interestingly, recent data clearly demon-
strated that a distinct subset of CD19+ CD1dhigh CD5+ cells have
potent regulatory function (50). This was confirmed recently in the
murine model of EAE. Indeed, adoptive transfer of splenic IL-10
producing CD1dhigh CD5+ CD19+ B cells (named B10 cells)
normalizes EAE in B cell-depleted mice (51), showing that IL-10
produced by B cells that express CD5+ CD1d+ are able to mod-
ulate the differentiation of CD4+ Th1 cells. The fact that IL-10–
producing B cells express CD1d and CD5 either in vitro after L.
major stimulation or in vivo 1 d postinfection with L. major
strongly suggests that these IL-10–producing B cells correspond
to the described B10 cells.
The results reported in this study clearly indicate that IL-10 se-
creted by CD5+ CD1d+ B cells is required for polarization of Th cell
response toward Th2 phenotype and susceptibility to infection with
L.majorLV39. This could be the result of the regulation of the IL-12
production. Understanding molecular mechanisms involved in
controlling B cell regulatory functions remains an important issue
that deserves further studies to design new strategies for manipu-
lating the development of effectors responses to the host’s benefit.
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